Justifying the Value of Personalized Medicine

Matthew C. Palmgren, PharmD

Video Categories: Value

Matthew Palmgren presents the key issues that help justify the value and cost of personalized medicines

Related Videos

January 16, 2019

Navigating the CMS 14-Day Rule in Biomarker Testing

Drs. David Rimm and Roy Herbst review the problems with the CMS “14-Day Rule†since some of the multigene panel biomarker tests require 21 days or longer to complete.

March 31, 2015

Challenge of Sustainable Pricing Model

Alexander Bastian speaks about the need for a sustainable model of pricing as related to cancer treatments and drug development. He talks about indication-based pricing or tumor-based pricing—says that is compelling, but not necessarily possible in the US.